Phone: 212-543-4506

Email: rynnm@childpsych.columbia.edu

CUCARD staff e-mail is only used for administrative communication such as making or rescheduling appointments.
**Our staff only checks email during business hours.**
Please do not use e-mail for any communication about your clinical condition with staff unless agreed upon by prior arrangement with your therapist.
Please do not use e-mail for emergencies. In case of emergency, please call 911 or go to your nearest emergency room.

Dr. Moira Rynn is Deputy Director of Research in the Division of Child and Adolescent Psychiatry, Department of Psychiatry at Columbia University (CU)/ New York State Psychiatric Institute (NYSPI). She is the Medical Director of CUCARD and Director of the Children’s Day Unit and the Child and Adolescent Psychiatric Evaluation Service at NYSPI and CU. Dr. Rynn was recruited to NYSPI/CU in 2006.

Previously she had been the Medical Director of the Mood and Anxiety Disorders Section of the Department of Psychiatry at the University of Pennsylvania School Of Medicine (PENN) since 1998. Dr. Rynn joined the Department of Psychiatry at PENN in 1991 as a resident and during her last year of residency served as Chief Resident. In 1997, she completed the Child and Adolescent Psychiatry Fellowship at the Children’s Hospital of Philadelphia, Child Guidance Center, followed by a Neuropsychopharmacology Research Fellowship, sponsored by the NIMH at PENN.

Dr. Rynn’s area of research has been focused on pediatric psychopharmacology with an emphasis on anxiety disorders, specifically general anxiety disorder and obsessive compulsive disorder. Dr. Rynn completed several studies in the area of pediatric anxiety studies showing the efficacy of sertraline (Rynn et al., AJP, 2001) and venlafaxine ER (AJP, 2007).

Dr. Rynn participated as an investigator in the Pediatric OCD Treatment Study (POTS) Team (JAMA, 2004). Dr. Rynn as Co-Principal Investigator worked with Dr. Anne Marie Albano (Principal Investigator) on the largest published study in pediatric anxiety disorders, the Child Child/Adolescent Anxiety Multimodal Treatment Study (CAMS, NEJM, 2008) which showed the treatment efficacy of the combination of cognitive behavioral therapy and medication.

In addition she is working in collaboration with Dr. Blair Simpson at NYSPI/CU examining the efficacy of novel compounds for the treatment of pediatric obsessive compulsive disorder. Dr. Rynn has been providing pharmacologic treatment for adults and children diagnosed with mood and anxiety disorders disorder since 1991. Dr. Rynn provides expert psychopharmacological treatment and consultation as part of the CUCARD team.

Specialties:

Child and Adolescent Psychiatry (Board Certified)

Psychiatry (Board Certified)

Education/Training

Medical School - University of Medicine and Dentistry of New Jersey

Internship - Hospital of the University of Pennsylvania

Residency - Children's Hospital of Philadelphia

Residency - Hospital of the University of Pennsylvania

Fellowship - Hospital of the University of Pennsylvania